论文部分内容阅读
目的 :探讨儿科细菌性呼吸道感染采用药物治疗的临床疗效与安全性。方法 :选取我院收治的100例细菌性呼吸道感染患儿依据随机法划分为参照组与研究组各50例。参照组50例患儿给予头孢他啶治疗,研究组50例患儿给予头孢硫脒治疗。对两组患儿临床治疗效果及不良反应进行比较。结果:研究组治疗有效率与参照组相当,P>0.05;研究组不良反应发生率与参照组相当,P>0.05。结论 :对细菌性呼吸道感染患儿给予小剂量头孢硫脒治疗与头孢他啶效果相当,且价格较低,不良反应少,值得推广。
Objective: To investigate the clinical efficacy and safety of drug treatment in pediatric bacterial respiratory infection. Methods: A total of 100 cases of bacterial respiratory tract infection admitted to our hospital were divided into the reference group and the study group according to the randomized method. 50 patients in the reference group were treated with ceftazidime and 50 in the study group were treated with cefathiamidine. The two groups of children with clinical treatment and adverse reactions were compared. Results: The treatment efficiency in study group was similar to that in reference group (P> 0.05). The incidence of adverse reactions in study group was similar to that in reference group (P> 0.05). Conclusion: The treatment of small dose ceftazidime in children with bacterial respiratory tract infection has the same effect with ceftazidime, with lower price and fewer adverse reactions, which is worth to be popularized.